Rigshospitalet
Department of Radiation Biology

Mikkel Staberg, M.Sc.

Email: mikkel.staberg@regionh.dk
Phone:  (+45) 35 456328
Fax: (+45) 35 456301
 
Date of Birth:
Febuary 24th, 1984
 
Current Position:
Ph.D student
 
 
Education:
2004-2010
Cand. Scient. in Biology, University of Copenhagen, Denmark
2000-2003Mathematical student, Gammel Hellerup Gymnasium, Denmark
2000Language school, the Leys Language school, Cambrigde, England
 

Research and Positions:
2013-Ph.D. student, Department of Radiation Biology, Copenhagen University Hospital, Denmark
2011-2013Research- and laboratory assistant, The Novo Nordisk Foundation Center for Protein Research, Panum Institute, University of Copenhagen, Denmark
2009-2010Master’s student, Protein Laboratory, Institute for Neuroscience and Pharmacology, Panum Institute, University of Copenhagen, Denmark
2008Project student, Section for Cell- and Developmental Biology, August Krogh Institute, University of Copenhagen, Denmark
2008Student assistant, Ferrosan A/S, Søborg, Denmark
 
2007-2008Bachelor student, Section for Cell- and Developmental Biology, August Krogh Institute, University of Copenhagen, Denmark
 

Teaching Experience:
2011Assistant teaching of Ph.D students in the course “Understanding Protein function through Chemical Biology” at Center for Protein Research, University of Copenhagen, Denmark
 

Awards, Grants and Scholarships:
2014Research grant from Dansk Kræftforsknings Fond
2013SUND Ph.D. scholarship
 
 
Courses:
2014Basic Flow cytometry and cell sorting, University of Copenhagen
2014Tumor Biology, BRIC and The Danish Cancer Society
2014FELASA C, University of Copenhagen
2013Clinical Cancer Research, Herlev Hospital, University of Copenhagen
2013Responsible Conduct of Research, University of Copenhagen
2011Working with small molecules in BiacoreTM, GE Healthcare, Uppsala, Sweden
2009Cellular Signalling, University of Copenhagen
2009Cancer biology, Roskilde University (RUC)
2009Immunology, Danmarks Technical University (DTU)
2009Cellulær og Integrativ Fysiologi, University of Copenhagen

 
Publications:
2013Staberg M, Riemer C, Xu R,  Dmytriyeva O, Bock E and Berezin V. Identification of a novel antagonist of the ErbB1 receptor capable of inhibiting migration of human glioblastoma cells.
Cell. Oncol. 2013 Apr 12. DOI: 10.1007/s13402-013-0128-6
2014Poulsen HS, Urup T, Michaelsen SR, Staberg M, Villingshøj M, Lassen U: The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients. Cancer Manag Res.2014:6 373–387
2016Staberg M, Michaelsen SR, Olsen LS, Nedergaard MK, Villingshøj M, Hamerlik P, Poulsen HS: Combined EGFR- and Notch inhibition display additive inhibitory effect on Glioblastoma cell viability and Glioblastoma-induced endothelial cell sprouting in vitro. Cancer Cell Int.2016 Apr 26; 16:34. doi: 10.1186. PMID: 27118928
2016Staberg M, Michaelsen SR, Rasmussen RD, Villingshøj M, Poulsen HS, Hamerlik P: Inhibition of histone deacetylases sensitizes glioblastoma cells to Lomustine. Cell Oncol (Dordr). 2016 Oct 20. PMID: 27766591
 
Conferences and Meetings:
2014Ph.D day, Graduate School of Health and Medical Sciences, Panum Institute, Copenhagen, Denmark
201427th Annual meeting 2014, Danish Association for Cancer Research
2014National annual PhD course in Oncology/Hematology in Denmark, Hotel Nyborg Strand, Nyborg, Denmark
2012Kick-off Meeting, Department of Radiation Biology, Hotel Kong Arthur, Copenhagen
2010The Spring Meeting, Protein Laboratory, Scandinavian Neuro-Oncology Society Meeting, Copenhagen

Oral presentation:
2015XI Northern Lights Symposium on Brain Tumors, Hindsgavl, Middelfart, Denmark
Inhibition of Notch- and EGFR signaling reduces cell viability and angiogenesis in glioblastoma
2016Scandinavian Society of Neuro-Oncology Meeting, Copenhagen:Staberg M, Michaelsen SR, Rasmussen RD, Villingshøj M, Hamerlik P, Poulsen HS; Inhibition of class I histone deacetylases sensitizes glioblastoma cells to lomustine treatment.
 
Poster presentation:
2015The 20th Annual SNO Scientific Meeting and Education Day, 2015 San Antonio, USA; Staberg M, Michaelsen SR, Olsen LS, Nedergaard MK,, Holst CB, Villingshøj M, Hamerlik P, Poulsen HS;Combined targeting of Notch and EGFR display additive inhibitory effects on angiogenesis and survival in glioblastoma.
2015The Annual American Association for Cancer Research (AACR), Philadelphia, Pennsylvania, USA;
Inhibition of Notch- and EGFR signaling reduces cell viability and angiogenesis in Glioblastoma.
Staber M, Michaelsen SR, Olsen LS, Nedergaard MK, Villingshøj M, Poulsen HS.
201427. årsmøde for Dansk Selskab for Cancerforskning, Vilvorde Kursuscenter and at Ph.D day, Graduate School of Health and Medical Sciences, Panum Institute, Copenhagen, Denmark Staberg M, Villingshøj M, Stockhausen MT, and Poulsen HS.
Expression and regulation of EGFRvIII in human GBM 
2012Streicher W, Andersen S, Staberg M, Björck L, and Wikström M.
Protein SIC: an intrinsically disordered protein that binds and inactivates innate immune system proteins and peptides

 

 

 

The Finsencenter, Section 6321, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen, Denmark